Directional Bilateral Thalamic Patterned Stimulation in Individuals with Essential Tremor

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Design: This study comprises two distinct phases. Phase 1 is a cross-sectional investigation designed to identify the optimal algorithm for patterned stimulation in the VIM region . Phase 2 is a prospective clinical trial focusing on the assessment of safety and efficacy of bilateral VIM-DBS in patients with essential tremor.

Objectives: The primary objective in Phase 2 is to evaluate the safety and effectiveness of bilateral VIM-DBS in individuals with essential tremor. In Phase 1, the investigators seek to explore the impact of the Chronos programming software on tremor patients who have experienced early or late loss of benefits.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: f
View:

• Phase 1: 5 to 10 tremor patients already treated with VIM-DBS but not doing well due to early and/or late loss of benefits (i.e. tremor scores ON stimulation identical or greater than before surgery in absence of stimulation).

• Phase 2: 10 Essential Tremor patients in need of DBS surgery.

• Written and signed Informed Consent.

• Age 18 to 85 years old.

• Subject must have Essential Tremor, as defined by all the following criteria: (a) isolated tremor syndrome consisting of bilateral action tremor; (b) at least three years duration; and (c) with or without tremor in other locations (e.g., head, voice, or low limbs) \[1\].

• Soft signs (categorizing patients as Essential Tremor-plus) will be allowed and noted in the patient's chart.

• Subject must be on stable dose of anti-tremor medication for at least 4 weeks prior to screening.

• Subject had no botulinum injection for at least three months prior to screening.

• Subject does not have a significant other medical condition biasing the study finding in investigator's opinion.

Locations
Other Locations
Canada
Movement Disorders Centre - Toronto Western Hospital
RECRUITING
Toronto
Time Frame
Start Date: 2024-07-16
Estimated Completion Date: 2027-01-01
Participants
Target number of participants: 15
Treatments
Experimental: Phase 1
5 to 10 patients with tremor already treated with VIM-DBS but not doing well because of early or late loss of benefits will be recruited by the PI over a 6 months period. If interested, the potential participants will be screened, informed, and consented by a research coordinator. Before the replacement of their IPG (implantable pulse generator), a baseline measurement will be performed.
Experimental: Phase 2
Ten patients with ET needing DBS-VIM surgery will be recruited and will receive Boston Scientific Genus IPG bilaterally connected to Boston Scientific Cartesia™ 8-contact Directional Leads. The programming will be done in four different settings/periods during the course of 8 months.
Sponsors
Collaborators: Boston Scientific Corporation
Leads: Alfonso Fasano

This content was sourced from clinicaltrials.gov

Similar Clinical Trials